FDA Adverse Event Injury Summary report: N

GYNECARE TVT SECUR SYSTEM

MDR report key: 3181821 · Received June 21, 2013

Report

Report Number
2210968-2013-10712
Event Type
Injury
Date Received
June 21, 2013
Report Date
July 5, 2016
Manufacturer
ETHICON INC.
Product Code
PAH
PMA / PMN Number
K052401
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4): IT WAS REPORTED THAT MESH WAS IMPLANTED ON (B)(6) 2008 ALONG WITH CONCURRENT HYSTERECTOMY DUE TO SYMPTOMATIC PELVIC RELAXATION, UTERINE PROLAPSE, MENORRHAGIA WITH ASSOCIATED ANEMIA.

Additional Manufacturer Narrative · 1

(B)(4). A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT MESH WAS IMPLANTED WITH CONCURRENT HYSTERECTOMY, ENTEROCELE CLOSURE, TRANSVAGINAL TAPE BLADDER SUSPENSION, ANTERIOR VAGINAL REPAIR, PERINEOPLASTY AND BIOMET PLATELET APPLICATION FOR ADHESION PREVENTION. IT WAS ALSO REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, INFECTION, URINARY PROBLEMS AND DYSPAREUNIA. NO ADDITIONAL INFORMATION WAS PROVIDED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2008 AND MESH WAS IMPLANTED. IT WAS REPORTED THAT SHE EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
283044 GYNECARE TVT SECUR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC PAH ETHICON INC. UNK 3041482

Patients

Seq Age Sex Outcome Treatment
1 26 YR Required Intervention